EGFR and neoplasm: Two of those four cases had evidence of ctDNA in the 12-month plasma sample, one with an EGFR p. (L747_S752del) in both the tumor and plasma (plasma VAF 2.65%) and the other with an EGFR p. (E746_A750del) in both the tumor and plasma (plasma VAF 1.1%).